Abstract
We report on a 38-year-old male diagnosed with biopsy-proven bladder urothelial carcinoma metastatic to the bone, who had a complete response to neoadjuvant chemotherapy consisting of carboplatin and gemcitabine. The final pathology of his radical cystoprostatectomy revealed no residual cancer. The patient continues to be without evidence of disease 2 years postoperatively. This case shows that neoadjuvant chemotherapy with nonstandard regimens can yield responses in patients with bone metastases.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 403-406 |
| Number of pages | 4 |
| Journal | Urologic Oncology: Seminars and Original Investigations |
| Volume | 24 |
| Issue number | 5 |
| DOIs | |
| State | Published - Sep 2006 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Chemotherapy
- Cystectomy
- Metastasis
- Survival
- Urothelial carcinoma
Fingerprint
Dive into the research topics of 'Complete response of bony metastatic bladder urothelial cancer to neoadjuvant chemotherapy and cystectomy'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS